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General Experimental Section.  NMR spectra were recorded on an Oxford 300 MHz
NMR spectrometer running Varian VNMR software.  Chemical shifts are reported in
parts per million (ppm) downfield from tetramethylsilane (TMS) with reference to
internal solvent.  Multiplicities are abbreviated as follows: singlet (s), doublet (d), triplet
(t), quartet (q), quintet (quint), multiplet (m), and broad (br).  Spectroscopic data is
provided for the major olefin isomer.  For all vinylboronates reported the 13C peak of the
α-carbon is not observed due to the large quadrupolar effect of the attached boron
nucleus.  E/Z ratios given for the products indicate the ratios of the C=C bond formed in
cross-metathesis and were determined from coupling constants of vinylic protons in the
1H NMR spectrum.
Analytical thin-layer chromatography (TLC) was performed using silica gel 60
F254 precoated plates (0.25 mm thickness) with a fluorescent indicator.  Visualization
was performed with standard potassium permanganate stains or UV light.  Flash column
chromatography was performed using silica gel 60 (230-400 mesh).  All glassware was
either oven dried or flame dried, and reactions were done under an atmosphere of argon.
All commercial chemicals were used as obtained except 1,4-diacetoxy-cis-2-butene,
S-2
which was distilled from CaH2.  3-Methyl-1,3-pentadiene was received (Aldrich) as a
70:30 mixture of E/Z isomers, and both isomers underwent cross-metathesis in the
examples below (NMR spectral data is given for both isomers whenever it could be
determined).  Benzene and methylene chloride were dried by passage through solvent
columns containing activated alumina.  (2Z,4E)-2-Bromo-ethyl-sorbatei (9) (which was
isolated and used as a 9:1 mixture of (2Z,4E)-2-bromo-ethyl-sorbate and (2E,4E)-2-
bromo-ethyl-sorbate), 1,1-dibromo-1,3-pentadieneii (15), and 2-hexylbuta-1,3-dieneiii (36)
were prepared according to literature procedures. Non-commercially available conjugated
dienes were prepared as follows:
I
MgBr
Pd(PPh3)4 (5 mol %)
THF/benzene, rt
29
Diene 29. To a solution of Pd(PPh3)4 (340 mg, 0.29 mmol) in 30 mL benzene at rt was
added (E)-4-iodo-4-octeneiv (1.4 g, 5.9 mmol) and vinylmagnesium bromide (1M in THF,
11.8 mL, 11.8 mmol).  After 3 h, saturated aqueous NH4Cl was added and the mixture
was extracted with 3 × 25 mL Et2O.  The organics were combined, washed with saturated
aqueous NaHCO3, water, brine, dried over MgSO4, and concentrated.  The crude oil was
purified by flash chromatography (hexanes) to give 0.52 g (64%) 29 as a colorless liquid.
1H NMR (300 MHz, CDCl3, ppm): δ 6.68 (dd, J = 17.6, 11.0 Hz, 1H), 5.38 (t, J = 7.4 Hz,
1H), 5.21 (d, J = 17.9 Hz, 1H), 5.06 (dt, J = 11.0, 1.6 Hz, 1H), 2.11-2.19 (m, 4H), 1.34-
1.57 (m, 4H), 0.91 (t, J = 7.4 Hz, 3H), 0.90 (t, J = 7.4 Hz, 3H).  13C NMR (75 MHz,
S-3
CDCl3, ppm): δ 136.6, 133.2, 130.9, 113.0, 35.7, 29.6, 23.3, 22.1, 14.2, 14.0.  HRMS (EI)
calc. for C10H18: 138.1409, found 138.1406.
OTBSOTBS
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Pd(PPh3)4 (5 mol %)
THF/benzene, rt
37
Diene 37. Following the same procedure as 29, 3-bromo-3-buten-1-ol t-
butyldimethylsilyl etherv (1.0 g, 3.8 mmol), vinylmagnesium bromide (1M in THF, 7.5
mL, 7.5 mmol), and Pd(PPh3)4 (218 mg, 0.19 mmol) in 20 mL benzene gave 0.61 g
(76%) of 37 as a colorless liquid.  1H NMR (300 MHz, CDCl3, ppm): δ 6.36 (dd, J = 17.6,
11.3 Hz, 1H), 5.24 (d, J = 17.6 Hz, 1H), 5.06 (d, J = 11.0 Hz, 1H), 5.06 (broad s, 1H),
5.03 (broad s, 1H), 3.74 (t, J = 7.1Hz, 2H), 2.46 (t, J = 7.1 Hz, 2H), 0.90 (s, 9H) 0.05 (s,
6H).  13C NMR (75 MHz, CDCl3, ppm): δ 143.4, 139.1, 117.6, 113.5, 62.6, 35.2, 26.1,
18.6, -5.0.  HRMS (EI) calc. for C12H24OSi: 212.1597, found 212.1592.
OTBSOTBS
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Diene 38.  Following the same procedure as 29, 1-(t-butyldimethylsiloxy)-2-
iodopropeneiv,vi (1.3 g, 4.4 mmol), vinylmagnesium bromide (1M in THF, 8.7 mL, 8.7
mmol), and Pd(PPh3)4 (252 mg, 0.22 mmol) in 23 mL benzene gave 0.24 g (28%) of 38
as a colorless liquid.  1H NMR (300 MHz, CDCl3, ppm): δ 6.39 (dd, J = 17.9, 11.0 Hz,
1H), 5.33 (br s, 1H), 5.17 (d, J = 18.1 Hz, 1H), 5.11 (br s, 1H), 5.04 (d, J = 11.0 Hz, 1H),
4.35 (t, J = 1.5 Hz, 2H), 0.93 (s, 9H), 0.09 (s, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ
145.1, 136.8, 114.9, 113.2, 62.6, 26.1, 18.6, -5.2.  HRMS (EI) calc. for C11H22OSi:
198.1440, found 198.1449.
General Procedure for Cross-Metathesis Reactions with (2Z,4E)-2-Bromo-ethyl-
sorbate and 1,1-Dibromo-1,3-pentadiene (Table 1).  Entry 1, (2Z,4E)-ethyl 2-
bromoundeca-2,4-dienoate (16).  To a solution of catalyst 3 (20 mg, 0.023 mmol) in 2.3
mL CH2Cl2 was added (2Z,4E)-2-bromo-ethyl-sorbate (9) (100 mg, 0.46 mmol) and
allylbenzene (10) (162 mg, 1.4 mmol), and the solution stirred for 12 h at 40 °C.  The
volatiles were removed by rotary evaporation, and the residue was purified by flash
chromatography to give 92 mg (68%, 8.5:1 E/Z) 16 as a colorless oil.  1H NMR (300
MHz, CDCl3, ppm): δ 7.70 (d, J = 10.5 Hz, 1H), 7.21-7.39 (m, 5H), 6.56-6.64 (m, 1H),
6.47 (dt, J = 15.5, 6.7 Hz, 1H), 4.32 (q, J = 7.0 Hz, 2H), 3.59 (d, J = 6.7 Hz, 2H), 1.37 (t,
J = 7.0 Hz, 3H).  13C NMR (75 MHz, CDCl3, ppm): δ 165.0, 145.0, 140.92, 138.4, 128.6,
128.5, 128.4, 126.5, 113.2, 62.3, 39.7, 14.2.  GC-MS (EI): 296 (M+), 294 (M+), 215, 169,
141.
Entry 2, (2Z,4E)-ethyl 2-bromo-5-phenylpenta-2,4-dienoate (17).i  Following the
general procedure for 16, 9 (73 mg, 0.33 mmol), styrene (11) (104 mg, 1.0 mmol), and 3
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(30 mg, 0.033 mmol) in 1.8 mL CH2Cl2 gave 60 mg (65%, 10:1 E/Z) of 17 as a colorless
oil.  1H NMR (300 MHz, CDCl3, ppm): δ 7.86 (d, J = 10.0 Hz, 1H), 7.55-7.58 (m, 2H),
7.38-7.41 (m, 3H), 7.07-7.25 (m, 2H), 4.35 (q, J = 7.0 Hz, 2H), 1.40 (t, J = 7.0 Hz, 3H).
13C NMR (75 MHz, CDCl3, ppm): δ 162.9, 142.6, 141.1, 135.9, 129.5, 128.8, 127.5,
125.2, 114.3, 62.4, 14.2.
Entry 3, (2Z,4E)-ethyl 6-acetoxy-2-bromohexa-2,4-dienoate (18).  Following the
general procedure for 16, 9 (132 mg, 0.60 mmol), 1,4-diacetoxy-cis-2-butene (12) (311
mg, 1.80 mmol), and 3 (51 mg, 0.060 mmol) in 3 mL CH2Cl2 gave 117 mg (70%, 7.5:1
E/Z) of 18 as a colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 7.63 (d, J = 10.6 Hz,
1H), 6.67 (ddt, J = 15.5, 10.7, 1.7 Hz, 1H), 6.29-6.38 (ddt, J = 15.5, 5.6, 0.9 Hz, 1H), 4.73
(dd, J = 5.6, 1.5 Hz, 2H), 4.32 (q, J = 7.0 Hz, 2H), 2.14 (s, 3H), 1.37 (t, J = 7.0 Hz, 3H).
13C NMR (75 MHz, CDCl3, ppm): δ 170.5, 163.7, 139.7, 137.9, 129.4, 115.7, 63.8, 62.9,
20.8, 14.1.  GC-MS (EI): 278 (M+), 276 (M+), 215, 169, 141.
Entry 4, (2Z,4E)-ethyl 2-bromo-6-chlorohexa-2,4-dienoate (19).  Following the
general procedure for 16, 9 (92 mg, 0.42 mmol), 1,4-dichloro-cis-2-butene (13) (105 mg,
0.84 mmol), and 3 (18 mg, 0.021 mmol) in 2 mL CH2Cl2 gave 51 mg (48%, 6:1 E/Z) of
19 as a colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 7.64 (d, J = 10.5 Hz, 1H), 6.72
(dd, J = 15.5, 10.5 Hz, 1H), 6.56 (dt, J = 15.5, 7.2 Hz, 1H), 4.29 (q, J = 7.2 Hz, 2H), 4.17
(d, J = 7.2 Hz, 2H), 1.34 (t, J = 7.2 Hz, 3H).  13C NMR (75 MHz, CDCl3, ppm): δ 162.4,
139.1, 138.5, 130.3, 116.3, 62.7, 47.3, 14.3.
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Entry 6, (E)-methyl 5,5-dibromopenta-2,4-dienoate (20).  Following the general
procedure for 16, 15 (150 mg, 0.66 mmol), methyl acrylate (14) (114 mg, 1.33 mmol),
and 3 (28 mg, 0.033 mmol) in 3.3 mL CH2Cl2 gave 70 mg (39%, >20:1 E/Z) of 20 as a
colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 7.16 (dd, J = 16.6, 12.8 Hz, 1H), 6.84
(d, 12.8 Hz, 1H), 5.90 (d, 16.6 Hz, 1H), 3.61 (s, 1H).  13C NMR (75 MHz, CDCl3, ppm):
δ 166.9, 140.1, 135.1, 124.1, 100.7, 52.3.  HRMS (EI) calc. for C6H6Br2O2: 269.8735,
found 269.8725.
Entry 7, (E)-1-(4,4-dibromobuta-1,3-dienyl)benzene (21).  Following the general
procedure for 16, 15 (150 mg, 0.66 mmol), styrene (11) (138 mg, 1.33 mmol), and 3 (28
mg, 0.033 mmol) in 3.3 mL CH2Cl2 gave 115 mg (60%, >20:1 E/Z) of 21 as a colorless
oil.  1H NMR (300 MHz, CDCl3, ppm): δ 7.44-7.47 (m, 2H), 7.25-7.38 (m, 3H), 7.10 (d, J
= 8.9 Hz, 1H), 6.68-6.84 (m, 2H).  13C NMR (75 MHz, CDCl3, ppm): δ 137.0, 136.2,
135.6, 128.7, 128.5, 126.7, 125.2, 91.3.  HRMS (EI) calc. for C10H8Br2: 287.8972, found
287.8981.
Entry 8, (E)-8,8-dibromoocta-5,7-dienyl acetate (22).  Following the general procedure
for 16, 15 (150 mg, 0.66 mmol), 5-hexenyl acetate (5) (189 mg, 1.33 mmol), and 3 (28
mg, 0.033 mmol) in 3.3 mL CH2Cl2 gave 122 mg (56%, 5:1 E/Z ratio) of 22 as a colorless
oil.  1H NMR (300 MHz, CDCl3, ppm): δ 6.86 (d, J = 10.0 Hz, 1H), 6.05 (ddt, J = 15.2,
10.0, 2.6 Hz, 1H), 5.85 (dt, J = 15.2, 7.0 Hz, 1H), 4.02 (t, J = 6.5 Hz, 2H), 2.06-2.15 (m,
2H), 2.00 (s, 3H), 1.55-1.65 (m, 2H), 1.39-1.50 (m, 2H).  13C NMR (75 MHz, CDCl3,
S-7
ppm): δ 171.0, 138.5, 136.8, 127.5, 88.7, 64.1, 32.6, 28.0, 25.0, 20.9.  HRMS (EI) calc.
for C10H14Br2O2: 325.9361, found 325.9346.
General Procedure for Cross-Metathesis Reactions Using 1,2-Disubstituted 1,3-
Butadienes (Table 2).  Entry 1, 4,4,5,5-Tetramethyl-2-((1E,3E)-3-methylpenta-1,3-
dienyl)-1,3,2-dioxaborolane and 4,4,5,5-tetramethyl-2-((1E,3Z)-3-methylpenta-1,3-
dienyl)-1,3,2-dioxaborolane (30).  To a solution of 3 (14 mg, 0.016 mmol) in CH2Cl2 (1
mL) was added 3-methyl-1,3-pentadiene (28) (27 mg, 0.32 mmol) and vinylboronate 23
(50 mg, 0.32 mmol).  The solution stirred at 40 °C for 12 h, and the solvent was removed
by rotary evaporation.  The crude product was purified by flash chromatography (5%
ethyl acetate:hexanes) to give 54 mg (80%, >20:1 E/Z) of the two isomers of 30.  A small
amount (10%) of the cross product missing the terminal methyl group (25) was identified
by a broad singlet at 5.15 ppm in the 1H NMR spectrum (terminal C=CH2) and by HRMS
(EI) (calc. for C11H19BO2: 194.1478, found 194.1485).  1H NMR (300 MHz, CDCl3,
ppm): δ 7.47 (d, J = 18.1 Hz, 1H, Z-isomer), 7.03 (d, J = 18.1 Hz, 1H, E-isomer), 5.76 (q,
J = 6.8 Hz, 1H, E-isomer), 5.62 (m, 1H, Z-isomer), 5.55 (d, J = 18.1 Hz, 1H, Z-isomer),
5.42 (d, J = 18.1 Hz, 1H, E-isomer), 1.78 (d, J = 11.0 Hz, 3H), 1.73 (s, 3H), 1.26 (s, 12H).
13C NMR (75 MHz, CDCl3, ppm) of E-isomer: δ 154.7, 131.9, 129.1, 83.2, 25.0, 14.5,
11.5.  HRMS (EI) calc. for C12H21BO2 (for both isomers): 208.1635, found 208.1636 and
208.1627.
Entry 2, (2E,4E)-4-methylhexa-2,4-dienyl acetate and (2E,4Z)-4-methylhexa-2,4-
dienyl acetate (31).  Following the general procedure for 30, 3-methyl-1,3-pentadiene
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(28) (40 mg, 0.49 mmol), 1,4-diacetoxy-cis-2-butene (12) (167 mg, 0.97 mmol), and 3
(21 mg, 0.024 mmol) in 1.5 mL CH2Cl2 gave 62 mg (82%, >20:1 E/Z) of 31 as a
colorless oil.  A small amount (9%) of the cross product missing the terminal methyl
group was identified by a broad singlet at 5.00 ppm in the 1H NMR spectrum (terminal
C=CH2) and by HRMS (EI) (calc. for C8H12O2: 140.0837, found 140.0841).  1H NMR
(300 MHz, CDCl3, ppm): δ 6.71 (d, J = 15.5 Hz, 1H, Z-isomer), 6.29 (d, J = 15.7 Hz, 1H,
E-isomer), 5.44-5.77 (m, 2H, both E- and Z-isomers), 4.64 (d, J = 7.1 Hz, 2H, Z-isomer),
4.59 (d, J = 7.4 Hz, 2H, E-isomer), 2.06 (s, 3H, Z-isomer), 2.05 (s, 3H, E-isomer), 1.81
(d, J = 15.9 Hz, 3H, both isomers), 1.72 (s, 3H, E-isomer), 1.70 (s, 3H, Z-isomer).  13C
NMR (75 MHz, CDCl3, ppm) of E-isomer: δ 171.1, 139.8, 133.8, 128.8, 119.5, 65.7,
21.2, 14.1, 12.1.  HRMS (EI) calc. for C9H14O2 (for both isomers): 154.0994, found
154.0987 and 154.0994.
Entry 3, (3E,5E)-5-methylhepta-3,5-dien-2-one and (3E,5Z)-5-methylhepta-3,5-dien-
2-one (32).  Following the general procedure for 30, 3-methyl-1,3-pentadiene (28) (40
mg, 0.49 mmol), methylvinylketone (26) (34 mg, 0.49 mmol), and 3 (21 mg, 0.024
mmol) in 1.5 mL CH2Cl2 gave 42 mg (70%, >20:1 E/Z) of 32 as a colorless oil.  A small
amount (7%) of the cross product missing the terminal methyl group was identified by a
broad singlet at 5.40 ppm in the 1H NMR spectrum (terminal C=CH2) and by HRMS (EI)
(calc. for C7H10O: 110.0732, found 110.0727).  1H NMR (300 MHz, CDCl3, ppm): δ 7.26
(d, J = 15.7 Hz, 1H, Z-isomer), 7.14 (d, J = 15.9 Hz, 1H, E-isomer), 6.15 (d, J = 15.9 Hz,
1H, Z-isomer), 6.05 (d, J = 15.9 Hz, 1H, E-isomer), 6.01 (q, J = 7.1 Hz, 1H, E-isomer),
5.88 (q, J = 7.1 Hz, 1H, Z-isomer), 2.32 (s, 3H, Z-isomer), 2.26 (s, 3H, E-isomer), 1.87-
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1.90 (m, 3H, Z-isomer), 1.83-1.87 (m, 3H, Z-isomer), 1.81 (d, J = 7.1 Hz, 3H, E-isomer),
1.76 (s, 3H, E-isomer).  13C NMR (75 MHz, CDCl3, ppm) of E-isomer: δ 199.2, 148.8,
137.7, 134.3, 125.1, 31.8, 27.5, 22.9.  HRMS (EI) calc. for C8H12O (for both isomers):
124.0888, found 124.0882 and 124.0886.
Entry 4, (5E,7E)-7-propylundeca-5,7-dienyl acetate (33).  Following the general
procedure for 30, diene 29 (40 mg, 0.29 mmol), 5-hexenyl acetate (5) (165 mg, 1.2
mmol), and 3 (12 mg, 0.014 mmol) in 1.2 mL CH2Cl2 gave 56 mg (77%, >20:1 E/Z) of
33 as a colorless oil.  The product was not separated from unreacted 5 (1.0:0.32 33/5).  A
small amount (12%) of the cross product missing the terminal methyl group was
identified by 2 broad singlets at 5.84 and 5.88 ppm in the 1H NMR spectrum (terminal
C=CH2).  1H NMR (300 MHz, CDCl3, ppm): δ 6.31 (d, J = 15.7 Hz, 1H), 5.64 (dt, J =
15.7, 6.9 Hz, 1H), 5.24 (t, J = 7.1 Hz, 1H), 4.06 (t, J = 6.6 Hz, 2H), 2.06-2.19 (m, 6H),
2.04 (s, 3H), 1.58-1.70 (m, 2H), 1.38-1.52 (m, 6H), 0.89 (q, J = 6.0 Hz, 6H).  13C NMR
(75 MHz, CDCl3, ppm): δ 171.4, 136.1, 129.2, 128.7, 127.0, 64.6, 36.5, 33.1, 29.6, 28.3,
26.1, 23.3, 22.2, 21.2, 14.2, 14.0.  HRMS (EI) calc. for C16H28O2: 252.2089, found
252.2094.
Entry 5, (2E,4E)-4-propylocta-2,4-dienyl benzoate (34).  Following the general
procedure for 30, diene 29 (40 mg, 0.29 mmol), 1,4-dibenzoyl-2-butene (27) (171 mg,
0.58 mmol), and 3 (12 mg, 0.014 mmol) in 1.4 mL CH2Cl2 gave 62 mg (79%, >20:1 E/Z)
of 34 as a colorless oil.  The product was not separated from allyl benzoate formed in the
reaction (1.0:0.25 34/allyl benzoate).  1H NMR (300 MHz, CDCl3, ppm): δ 8.05-8.10 (m,
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2H), 7.52-7.59 (m, 1H), 7.41-7.48 (m, 2H), 6.70 (dd, J = 15.8, 1.1 Hz, 1H), 5.88 (dt, J =
15.7, 6.3 Hz, 1H), 5.43 (t, J = 7.4 Hz, 1H), 4.91 (dd, J = 6.6, 1.1 Hz, 2H), 2.12-2.21 (m,
4H), 1.35-1.55 (m, 4H), 0.92 (t, J = 7.4 Hz, 3H), 0.91 (t, J = 7.4 Hz, 3H).  13C NMR (75
MHz, CDCl3, ppm): δ 166.6, 135.4, 133.1, 132.1, 131.2, 129.8, 128.8, 128.5, 122.2, 66.5,
36.2, 29.7, 23.3, 22.0, 14.2, 14.0.  HRMS (EI) calc. for C18H24O2: 272.1776, found
272.1777.
General Procedure for Cross-Metathesis Reactions Using 2-Substituted 1,3-
Butadienes (Table 3).  Entry 1, (E)-4-methylenedec-2-enyl acetate (36).  To a solution
of 3 (12 mg, 0.014 mmol) in benzene (1.5 mL) was added 1,4-diacetoxy-cis-2-butene
(12) (100 mg, 0.58 mmol) and diene 35 (40 mg, 0.29 mmol).  The solution stirred at 60
°C for 12h, and the solvent was removed by rotary evaporation.  The crude product was
purified by flash chromatography (5% ethyl acetate:hexanes) to give 44 mg (72%, >20:1
E/Z) of a colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 6.23 (d, J = 16.0 Hz, 1H),
5.70 (dt, J = 15.7, 6.6 Hz, 1H), 4.96 (br s, 1H), 4.94 (br s, 1H), 4.55 (dd, J = 6.3, 1.1 Hz,
2H), 2.11 (t, J = 7.0 Hz, 2H), 2.01 (s, 3H), 1.36-1.43 (m, 2H), 1.18-1.27 (m, 6H), 0.80-
0.84 (m, 3H).  13C NMR (75 MHz, CDCl3, ppm): δ 171.0, 145.6, 136.8, 122.4, 116.7,
65.4, 32.0, 31.9, 29.4, 28.2, 22.8, 21.2, 14.3.  HRMS (EI) calc. for C13H22O2: 210.1620,
found 210.1616.
Entry 2, (E)-4-methylenedec-2-enyl benzoate (39).  Following the general procedure
for 36, diene 35 (40 mg, 0.29 mmol), 1,4-dibenzoyl-2-butene (27) (171 mg, 0.58 mmol),
and 3 (12 mg, 0.014 mmol) in 1.4 mL benzene gave 57 mg (73%, >20:1 E/Z) of 39 as a
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colorless oil.  The product was not separated from allyl benzoate formed in the reaction
(1.0:0.46 39/allyl benzoate).  1H NMR (300 MHz, CDCl3, ppm): δ 8.05-8.09 (m, 2H),
7.53-7.60 (m, 1H), 7.44 (t, J = 7.4 Hz, 2H), 6.40 (d, J = 15.7 Hz, 1H), 5.90 (dt, J = 15.9,
6.3 Hz, 1H), 5.06 (br s, 1H), 5.03 (br s, 1H), 4.88 (dd, J = 6.3, 1.1 Hz, 2H), 2.22 (t, J =
6.9 Hz, 2H), 1.45-1.58 (m, 2H), 1.27-1.36 (m, 6H), 0.86-0.91 (m, 3H).  13C NMR (75
MHz, CDCl3, ppm): δ 166.6, 145.6, 136.8, 133.2, 133.1, 129.8, 128.5, 122.6, 116.7, 65.8,
32.1, 31.9, 29.4, 28.2, 22.8, 14.2.  HRMS (EI) calc. for C18H24O2: 272.1776, found
272.1778.
Entry 3, (E)-4,4,5,5-tetramethyl-2-(3-methylenenon-1-enyl)-1,3,2-dioxaborolane
(40).  Following a slight modification of the general procedure for 36, vinyl boronate 23
(89 mg, 0.58 mmol), diene 35, (40 mg, 0.29 mmol), and 3 (25 mg, 0.029 mmol) in 1.5
mL benzene for 2 h at 60 °C (followed by the same work-up) gave 56 mg (73%, >20:1
E/Z) of a yellow oil.  1H NMR (300 MHz, CDCl3, ppm): δ 7.03 (d, J = 18.4 Hz, 1H), 5.59
(d, J = 18.4 Hz, 1H), 5.16 (br s, 1H), 5.13 (br s, 1H), 2.20 (t, J = 7.4 Hz, 2H), 1.41-1.48
(m, 2H), 1.20-1.34 (m, 6H), 1.27 (s, 12H), 0.85-0.89 (m, 3H).  13C NMR (75 MHz,
CDCl3, ppm): δ 152.0, 147.6, 119.3, 83.4, 31.9, 31.5, 29.5, 28.5, 25.0, 22.9, 14.3.  HRMS
(EI) calc. for C16H29BO2: 264.2261, found 264.2251.
Entry 4, (E)-6-(tert-butyldimethylsilyloxy)-4-methylenehex-2-enyl benzoate (41).
Following the general procedure for 36, diene 37 (40 mg, 0.19 mmol), 1,4-dibenzoyl-2-
butene (27) (112 mg, 0.38 mmol), and 3 (8 mg, 0.009 mmol) in 1 mL benzene gave 46
mg (70%, >20:1 E/Z) of 41 as a colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 8.05-
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8.10 (m, 2H), 7.53-7.59 (m, 1H), 7.41-7.47 (m, 2H), 6.39 (d, J = 15.9 Hz, 1H), 5.92 (dt, J
= 15.9, 6.3 Hz, 1H), 5.12 (br s, 1H), 5.07 (br s, 1H), 4.88 (d, J = 6.3 Hz, 2H), 3.75 (t, J =
7.1 Hz, 2H), 2.47 (t, J = 7.1 Hz, 2H), 0.89 (s, 9H), 0.05 (s, 6H).  13C NMR (75 MHz,
CDCl3, ppm): δ 166.5, 142.3, 136.6, 133.2, 130.4, 129.8, 128.5, 122.9, 118.6, 65.7, 62.4,
35.7, 26.1, 18.5, -5.1.  HRMS (EI) calc. for C20H31O3Si [M+H]: 347.2043, found
347.2047.
Entry 5, (E)-9-(tert-butyldimethylsilyloxy)-7-methylenenon-5-enyl acetate (42).
Following the procedure for 36, diene 37 (40 mg, 0.19 mmol), 5-hexenyl acetate (5) (107
mg, 0.75 mmol), and 3 (8 mg, 0.009 mmol) in 1 mL benzene gave 46 mg (75%, >20:1
E/Z) of 42 as a colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 6.05 (d, J = 15.7 Hz,
1H), 5.69 (dt, J = 15.9, 6.9 Hz, 1H), 4.94 (br s, 1H), 4.88 (br s, 1H), 4.06 (t, J = 6.6 Hz,
2H), 3.71 (t, J = 7.1 Hz, 2H), 2.43 (t, J = 6.9 Hz, 2H), 2.13 (q, J = 6.9 Hz, 2H), 2.04 (s,
3H), 1.58-1.68 (m, 2H), 1.41-1.51 (m, 2H), 0.89 (s, 9H), 0.04 (s, 6H).  13C NMR (75
MHz, CDCl3, ppm): δ 171.4, 143.0, 132.7, 129.8, 115.3, 64.6, 62.8, 36.0, 32.5, 28.3,
26.2, 25.9, 21.2, 18.6, -5.1.  HRMS (EI) calc. for C18H35O3Si [M+H]: 327.2356, found
327.2366.
Entry 6, (E)-tert-butyldimethyl(3-methylene-5-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)pent-4-enyloxy)silane (43).  Following a slight modification of the
general procedure for 36, diene 37 (40 mg, 0.19 mmol), vinyl boronate 23 (59 mg, 0.38
mmol), and 3 (16 mg, 0.019 mmol) in 1 mL benzene for 2 h at 60 °C (followed by the
same work-up) gave 44 mg (69%, >20:1 E/Z) of 43 as a yellow oil.  1H NMR (300 MHz,
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CDCl3, ppm): δ 7.03 (d, J = 18.4 Hz, 1H), 5.60 (d, J = 18.4 Hz, 1H), 5.23 (br s, 1H), 5.18
(br s, 1H), 3.70 (t, J = 7.1 Hz, 2H), 2.46 (dt, J = 7.1, 1.1 Hz, 2H), 1.27 (s, 12H), 0.87 (s,
9H), 0.02 (s, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ 151.8, 144.1, 121.0, 83.4, 62.4,
35.0, 26.1, 25.0, 18.5, -5.1.  HRMS (EI) calc. for C18H35BO3Si: 338.2449, found
338.2455.
Entry 7, (E)-tert-butyldimethyl(2-methylene-4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)but-3-enyloxy)silane (44).  Following a slight modification of the
general procedure for 36, diene 38 (40 mg, 0.20 mmol), vinyl boronate 23 (62 mg, 0.40
mmol), and 3 (17 mg, 0.020) in 1 mL benzene for 2 h at 60 °C (followed by the same
work-up) gave 37 mg (approximately 73% pure; ~40% yield based on impurities and
unreacted, inseparable boronate 23, >20:1 E/Z) of impure 44 as a yellow oil.  Peaks given
in spectral data are only those corresponding to 44.  1H NMR (300 MHz, CDCl3, ppm): δ
7.06 (d, J = 18.9 Hz, 1H), 5.49 (q, J = 1.9 Hz, 1H), 5.48 (d, J = 18.7 Hz, 1H), 5.28 (br s,
1H), 4.36 (t, J = 1.6 Hz, 2H), 1.28 (s, 12H), 0.92 (s, 9H), 0.07 (s, 6H).
Entry 8, (E)-4-((tert-butyldimethylsilyloxy)methyl)penta-2,4-dienyl benzoate (45).
Following the general procedure for 36, diene 38 (40 mg, 0.20 mmol), 1,4-dibenzoyl-2-
butene (27) (119 mg, 0.40), and 3 (9 mg, 0.01 mmol) in 1 mL benzene gave 42 mg (63%,
>20:1 E/Z) of 45 as a pale yellow oil.  Compound 45 was not separated from allyl
benzoate formed in the reaction (1.0:0.55 45:allyl benzoate).  1H NMR (300 MHz,
CDCl3, ppm): δ 8.03-8.09 (m, 2H), 7.53-7.59 (m, 1H), 7.44 (t, J = 8.0 Hz, 2H), 6.40 (d, J
= 15.9 Hz, 1H), 5.87 (dt, J = 15.9, 6.3 Hz, 1H), 5.37 (br s, 1H), 5.17 (br s, 1H), 4.86 (d, J
S-14
= 6.3 Hz, 2H), 4.35 (s, 2H), 0.92 (s, 9H), 0.09 (s, 6H).  13C NMR (75 MHz, CDCl3, ppm):
δ 166.5, 144.0, 134.0, 133.2, 129.8, 128.5, 122.7, 118.4, 116.1, 65.8, 62.9, 26.1, 18.5,
—5.2.  HRMS (EI) calc. for C19H29O3Si [M+H]: 333.1886, found 333.1888.
(E)-1-(3-methylpenta-1,3-dienyl)benzene (46).  To a solution of 3 (14 mg, 0.016 mmol)
in benzene (1.5 mL) was added vinylboronate 23 (50 mg, 0.32 mmol) and diene 28 (26
mg, 0.32 mmol), and the solution stirred at 40 °C for 2.5 h.  The reaction solution was
cooled to rt, and Pd(PPh3)4 (11 mg, 0.0097 mmol), bromobenzene (50 mg, 0.32 mmol),
and NaOEt (2M in EtOH, 0.46 mL, 0.91 mmol) were added.  The solution stirred at 80
°C for 5 h.  The reaction mixture was purified by flash chromatography (100% hexanes)
to give 23 mg (45%) of 46 as a colorless oil.  A small amount (13%) of the cross product
missing the terminal methyl group was identified by two broad singlets at 5.09 ppm and
5.14 ppm in the 1H NMR spectrum (terminal C=CH2).  Characterization data matched
that in the literature.vii  1H NMR (300 MHz, CDCl3, ppm): δ 7.41-7.48 (m, 2H, both E-
and Z-isomers), 7.28-7.36 (m, 2H, both E- and Z-isomers), 7.18-7.26 (m, 1H, both E- and
Z-isomers), 6.90 (d, J = 16.2 Hz, 1H, Z-isomer), 6.83 (d, J = 16.2 Hz, 1H, E-isomer), 6.57
(d, J = 15.9 Hz, 1H, Z-isomer), 6.46 (d, J = 15.9 Hz, 1H, E-isomer), 5.73 (q, J = 7.1 Hz,
1H, E-isomer), 5.56 (q, J = 7.1 Hz, 1H, Z-isomer), 1.95 (m, 3H, Z-isomer), 1.88 (t, J = 1.1
Hz, 3H, E-isomer), 1.82 (d, J = 7.1 Hz, 3H, E-isomer); terminal methyl resonance of Z-
isomer overlaps with those of the major isomer.
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